Comparing the Effect of Dipeptidyl-Peptidase 4 Inhibitors and Sulfonylureas on Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Prospective Open-Label Study

Diabetic kidney disease (DKD) leads to substantial morbidity in patients with type 2 diabetes mellitus (T2DM). Evidence suggests that antidiabetic drug dipeptidyl-peptidase 4 (DPP-4) inhibitors may be able to attenuate albuminuria, whereas the influence of sulfonylureas on albuminuria remains unclea...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Po-Chung, Hsu, Shang-Ren, Kuo, Jeng-Fu, Cheng, Yun-Chung, Liu, Yu-Hsiu, Tu, Shih-Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832118/
https://www.ncbi.nlm.nih.gov/pubmed/31627406
http://dx.doi.org/10.3390/jcm8101715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832118/
https://www.ncbi.nlm.nih.gov/pubmed/31627406
http://dx.doi.org/10.3390/jcm8101715

Ejemplares similares